CD4 and neoplasm: These data suggested that lung tumors with Med23-deletion associate with the decreased tumor-inhibiting T cells (CD4+ T cells and CD8+ T cells) and an increase in tumor-promoting T cell (Foxp3+ Treg), which may constitute an immune microenvironment promoting the tumorigenesis in Med23-deficient mice.